Smart Bracelet Glucose Delivery for Immediate Hypoglycemia Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing glucose monitoring devices do not provide immediate access to glucose supplementation, leaving individuals at risk of severe hypoglycemic crises vulnerable to irreversible consequences.
Innovation Solution
A wearable smart device containing glucose and/or glucagon, equipped with a reloadable cartridge, nasal spray, and a smart valve, allowing quick administration via straw or spray, integrated with glucose and glucagon detection, and communication with CGM and insulin pumps for immediate glucose restoration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If glucose monitoring devices are used to detect hypoglycemia, then glucose levels can be monitored, but immediate glucose supplementation is not provided leaving patients vulnerable to severe hypoglycemic crises
Solution Approach 1:
The patent combines glucose monitoring, glucose storage, and glucose administration functions into a single integrated wearable device. The device includes a glucose sensor for detection, a reservoir for storing glucose solution, and an administration mechanism (such as a microneedle array or transdermal delivery system) that can immediately supplement glucose when hypoglycemia is detected, eliminating the gap between detection and treatment.
Solution Approach 2:
The wearable device performs multiple functions: it monitors glucose levels continuously, stores glucose supplementation solution, administers glucose when needed, and provides alert notifications. This multi-functional approach ensures that the device not only detects hypoglycemia but also immediately responds to it, providing comprehensive protection against severe hypoglycemic crises.
2Reliability
If glucose supplementation is administered quickly to prevent severe hypoglycemia, then patient safety is improved, but the device becomes more complex requiring integration of storage and delivery mechanisms
Solution Approach 1:
The device employs a nested structure where the glucose reservoir is integrated within the wearable body, and the administration mechanism (such as microneedles or transdermal channels) is contained within the device housing. This nested arrangement allows compact integration of multiple functions while maintaining a wearable form factor, reducing the complexity burden of having storage and delivery systems in one device.
Solution Approach 2:
The device is designed to automatically detect hypoglycemia through the glucose sensor and trigger glucose administration without requiring manual intervention from the patient. This self-service capability simplifies the user interaction while ensuring rapid response to hypoglycemic events, improving reliability without adding operational complexity.
3Reliability
If a wearable device contains glucose and glucagon for immediate restoration, then hypoglycemic crisis protection is enhanced, but the device size and complexity increase
Solution Approach 1:
The device incorporates separate compartments or reservoirs for glucose and glucagon solutions, each optimized for its specific function. The glucose reservoir is positioned for rapid administration in hypoglycemic events, while the glucagon component is integrated for counter-regulatory response. This localized organization of different substances within compact spaces minimizes overall device volume while maintaining enhanced restoration capabilities.
Solution Approach 2:
The device divides the glucose and glucagon storage and delivery systems into separate modular segments. This segmentation allows for efficient space utilization, independent optimization of each substance's storage and delivery mechanism, and potential flexibility in configuration to minimize overall device size while providing comprehensive glucose restoration capability.
Data Source
Figure 1
Figure 2
AI summary
"Smart bracelet device containing glucose and/or glucagon" Ergonomic, wearable smart device, containing predetermined quantities of glucose and/or glucagon adapted to restore the concentration of glucose in the blood comprising: - a body of the device (1) with tubular shape containing predetermined quantities of glucose and/or glucagon; - a reload valve (4) housing at least a lip (6.1) of a reload cartridge (6), adapted to restore the reserves of glucose and/or glucagon; - a straw (3), a nasal spray (11) or both adapted for the consumption of a predetermined quantity of glucose and/or glucagon; - a smart valve (2) adapted to receive information regarding the exact quantity to be administered; - a magnetic closure (5); - a reload cartridge (6) comprising a tank (6.2) and a lip (6.1); - a display (7); - a glycemia detector (8) adapted to check the quantity of glucose in the blood, adapted to interact with said display (7) with latest-generation cellular device, CGM, insulin pumps.